This program is intended to facilitate innovative research opportunities and supports basic science, as well as translational and/or clinical investigators. Our lab secured 2-year support to develop novel mouse models of ASD (Autism Spectrum Disorders) using targeted genome editing with CRISPR, in collaboration with Cathy Abbot's lab at IGMM.